These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 33805130)

  • 1. Development of a New Polymeric Nanocarrier Dedicated to Controlled Clozapine Delivery at the Dopamine D
    Łukasiewicz S
    Polymers (Basel); 2021 Mar; 13(7):. PubMed ID: 33805130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Encapsulation of clozapine in polymeric nanocapsules and its biological effects.
    Łukasiewicz S; Szczepanowicz K; Podgórna K; Błasiak E; Majeed N; Ogren SOÖ; Nowak W; Warszyński P; Dziedzicka-Wasylewska M
    Colloids Surf B Biointerfaces; 2016 Apr; 140():342-352. PubMed ID: 26774571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The interaction of clozapine loaded nanocapsules with the hCMEC/D3 cells - In vitro model of blood brain barrier.
    Łukasiewicz S; Błasiak E; Szczepanowicz K; Guzik K; Bzowska M; Warszyński P; Dziedzicka-Wasylewska M
    Colloids Surf B Biointerfaces; 2017 Nov; 159():200-210. PubMed ID: 28797970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine D2 and serotonin 5-HT1A receptor interaction in the context of the effects of antipsychotics - in vitro studies.
    Łukasiewicz S; Błasiak E; Szafran-Pilch K; Dziedzicka-Wasylewska M
    J Neurochem; 2016 May; 137(4):549-60. PubMed ID: 26876117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine D
    Kowalik A; Majerek M; Mrowiec K; Solich J; Faron-Górecka A; Woźnicka O; Dziedzicka-Wasylewska M; Łukasiewicz S
    Biomolecules; 2022 May; 12(6):. PubMed ID: 35740874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repeated Clozapine Increases the Level of Serotonin 5-HT
    Szlachta M; Kuśmider M; Pabian P; Solich J; Kolasa M; Żurawek D; Dziedzicka-Wasylewska M; Faron-Górecka A
    Front Mol Neurosci; 2018; 11():40. PubMed ID: 29497362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biocompatible Polymeric Nanoparticles as Promising Candidates for Drug Delivery.
    Łukasiewicz S; Szczepanowicz K; Błasiak E; Dziedzicka-Wasylewska M
    Langmuir; 2015 Jun; 31(23):6415-25. PubMed ID: 26013473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro interaction of polyelectrolyte nanocapsules with model cells.
    Łukasiewicz S; Szczepanowicz K
    Langmuir; 2014 Feb; 30(4):1100-7. PubMed ID: 24410319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The antipsychotics clozapine and olanzapine increase plasma glucose and corticosterone levels in rats: comparison with aripiprazole, ziprasidone, bifeprunox and F15063.
    Assié MB; Carilla-Durand E; Bardin L; Maraval M; Aliaga M; Malfètes N; Barbara M; Newman-Tancredi A
    Eur J Pharmacol; 2008 Sep; 592(1-3):160-6. PubMed ID: 18640111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-HT1A receptor agonist properties of the antipsychotic, nemonapride: comparison with bromerguride and clozapine.
    Assié MB; Cosi C; Koek W
    Eur J Pharmacol; 1997 Sep; 334(2-3):141-7. PubMed ID: 9369342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotonin receptors: their key role in drugs to treat schizophrenia.
    Meltzer HY; Li Z; Kaneda Y; Ichikawa J
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Oct; 27(7):1159-72. PubMed ID: 14642974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New insights into the biology of schizophrenia through the mechanism of action of clozapine.
    Brunello N; Masotto C; Steardo L; Markstein R; Racagni G
    Neuropsychopharmacology; 1995 Nov; 13(3):177-213. PubMed ID: 8602893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antipsychotic drugs which elicit little or no parkinsonism bind more loosely than dopamine to brain D2 receptors, yet occupy high levels of these receptors.
    Seeman P; Tallerico T
    Mol Psychiatry; 1998 Mar; 3(2):123-34. PubMed ID: 9577836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose-related effects of clozapine and risperidone on the pattern of brain regional serotonin and dopamine metabolism and on tests related to extrapyramidal functions in rats.
    Batool F; Hasnat A; Haleem MA; Haleem DJ
    Acta Pharm; 2010 Jun; 60(2):129-40. PubMed ID: 21134850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generalization of serotonin (5-HT)1A agonists and the antipsychotics, clozapine, ziprasidone and S16924, but not haloperidol, to the discriminative stimuli elicited by PD128,907 and 7-OH-DPAT.
    Dekeyne A; Rivet JM; Gobert A; Millan MJ
    Neuropharmacology; 2001 Jun; 40(7):899-910. PubMed ID: 11378160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formation of biocompatible nanocapsules with emulsion core and pegylated shell by polyelectrolyte multilayer adsorption.
    Szczepanowicz K; Hoel HJ; Szyk-Warszynska L; Bielańska E; Bouzga AM; Gaudernack G; Simon C; Warszynski P
    Langmuir; 2010 Aug; 26(15):12592-7. PubMed ID: 20604580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. S 16924 ((R)-2-[1-[2-(2,3-dihydro-benzo[1,4] dioxin-5-Yloxy)-ethyl]-pyrrolidin-3yl]-1-(4-fluoro-phenyl)-ethanone), a novel, potential antipsychotic with marked serotonin (5-HT)1A agonist properties: I. Receptorial and neurochemical profile in comparison with clozapine and haloperidol.
    Millan MJ; Gobert A; Newman-Tancredi A; Audinot V; Lejeune F; Rivet JM; Cussac D; Nicolas JP; Muller O; Lavielle G
    J Pharmacol Exp Ther; 1998 Sep; 286(3):1341-55. PubMed ID: 9732398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pegylated polyelectrolyte nanoparticles containing paclitaxel as a promising candidate for drug carriers for passive targeting.
    Szczepanowicz K; Bzowska M; Kruk T; Karabasz A; Bereta J; Warszynski P
    Colloids Surf B Biointerfaces; 2016 Jul; 143():463-471. PubMed ID: 27037784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Actions of novel antipsychotic agents on apomorphine-induced PPI disruption: influence of combined serotonin 5-HT1A receptor activation and dopamine D2 receptor blockade.
    Auclair AL; Kleven MS; Besnard J; Depoortère R; Newman-Tancredi A
    Neuropsychopharmacology; 2006 Sep; 31(9):1900-9. PubMed ID: 16421514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual ligands targeting dopamine D2 and serotonin 5-HT1A receptors as new antipsychotical or anti-Parkinsonian agents.
    Ye N; Song Z; Zhang A
    Curr Med Chem; 2014; 21(4):437-57. PubMed ID: 24164194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.